semaglutide patent expiration 2031 Novo Nordisk expiry opens door to cheaper weight-loss drugs in India Looming GLP-1 drug patent expirations

Our data showed that a combination of lower amounts of these four complementary substances was able to modulate and reduce the insulin response to the OGTT and to improve some aspects of the lipid profile (increasing HDL and reducing total cholesterol), similarly to what has previously been reported for each of them singly (12, 28-31)

Why this matters: Weight-loss plateaus often happen because single-pathway drugs give the body one route to adapt around

Man J, Chen H, Zhang T, Yin X, Yang X, Lu M

DPP-4 inhibitors carry a minimal risk of hypoglycemia and gastrointestinal symptoms

GPx activity varies by sample type and substrate, with the highest activity in erythrocytes, followed by liver, kidney, and serum